6533b827fe1ef96bd12864a0
RESEARCH PRODUCT
A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy
Ö. TüreciJessica C. HasselSebastian AttigAndreas PinterHeinrich HaasAndreas KuhnCarmen LoquaiL. HeesenR JabulowskyJ. UtikalStephan GrabbeL KranzPeter LangguthE. DerhovanessianMustafa DikenChristoffer GebhardtDirk JägerRoland KaufmannD Schwarck-kokarakisUgur Sahinsubject
0301 basic medicineMessenger RNAbusiness.industrymedicine.medical_treatmentMelanomaHematologyFirst in humanImmunotherapymedicine.diseaseClinical trial03 medical and health sciences030104 developmental biology0302 clinical medicinePhase i iiOncologyAntigen030220 oncology & carcinogenesisCancer researchmedicinebusinessLipoplexyear | journal | country | edition | language |
---|---|---|---|---|
2017-12-01 | Annals of Oncology |